The Lancet: August 19, 2011
The Lancet in conversation with - Ein Podcast von The Lancet Group - Freitags
Kategorien:
John Cleland discusses early trial findings about a myocin activator in the treatment of heart failure.Continue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv
